Pfizer
The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat the currently circulating Omicron BA.4/5 subvariants, days after endorsing a pair...
Coronavirus: Pfizer’s anti-Covid pill available next month
Cyprus expects to take delivery of Pfizer’s oral antiviral medicine Paxlovid for the treatment of Covid-19 in mid or late February and has ordered sufficient...
US FDA backs Pfizer’s COVID-19 booster shot for 12- to 15-year-olds (Updated)
The US Food and Drug Administration on Monday authorised the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children ages...
EU evaluating use of Pfizer’s Covid-19 vaccine in young children
The European Union’s medicines regulator said on Monday it has started evaluating the use of Pfizer Inc and BioNTech’s COVID-19 vaccine in children between five and...
Pfizer/BioNTech say data show Covid-19 vaccine safe and protective in kids
Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to...
Pfizer seeks to store vaccine at higher temperatures, easing logistics
Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially...
Coronavirus: people to be told in advance which vaccine they’ll receive
As the AstraZeneca vaccine is different from the other two – Pfizer and Moderna – already being used, the health ministry will in future inform...
Coronavirus: EMA says no specific safety concerns over Pfizer jab after Norway deaths
No specific safety concern has been identified for use of the Pfizer/BioNTech coronavirus vaccine in frail elderly individuals, the European Medicines Agency (EMA) said on...
Italy to take legal action on COVID vaccine delays to get doses
Italy will take legal action and step up pressure in Brussels against Pfizer Inc and AstraZeneca over delays in deliveries of COVID-19 vaccines with a view to...
EU states warn of risks to vaccination credibility as Pfizer slows supplies
European governments said the credibility of their COVID-19 vaccination programmes was at risk on Friday after U.S. pharmaceutical firm Pfizer announced a temporary slowdown of...